Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
Public ClinicalTrials.gov record NCT05206513. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of Valbenazine for the Treatment of Dyskinesia Due to Cerebral Palsy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the efficacy of valbenazine versus placebo on improving chorea in pediatric and adult participants who have dyskinesia due to cerebral palsy (DCP) with choreiform movements.
Study identification
- NCT ID
- NCT05206513
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 86 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 15, 2022 (Actual)
- Primary completion
- Oct 16, 2025 (Actual)
- Completion
- Mar 31, 2026 (Actual)
- Last update posted
- Apr 29, 2026
2022 – 2026
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Neurocrine Clinical Site | San Diego | California | 92123 | — |
| Neurocrine Clinical Site | Aurora | Colorado | 80045 | — |
| Neurocrine Clinical Site | Stamford | Connecticut | 06905 | — |
| Neurocrine Clinical Site | Gulf Breeze | Florida | 32561 | — |
| Neurocrine Clinical Site | Miami | Florida | 33155 | — |
| Neurocrine Clinical Site | Orlando | Florida | 32806 | — |
| Neurocrine Clinical Site | Chicago | Illinois | 60611 | — |
| Neurocrine Clinical Site | Baltimore | Maryland | 21205 | — |
| Neurocrine Clinical Site | Boston | Massachusetts | 02115 | — |
| Neurocrine Clinical Site | Farmington Hills | Michigan | 48334 | — |
| Neurocrine Clinical Site | Saint Paul | Minnesota | 55101 | — |
| Neurocrine Clinical Site | New York | New York | 10003 | — |
| Neurocrine Clinical Site | Cincinnati | Ohio | 45229 | — |
| Neurocrine Clinical Site | Columbus | Ohio | 43205 | — |
| Neurocrine Clinical Site | Oklahoma City | Oklahoma | 73120 | — |
| Neurocrine Clinical Site | Portland | Oregon | 97239 | — |
| Neurocrine Clinical Site | Dallas | Texas | 75390-8857 | — |
| Neurocrine Clinical Site | Fort Worth | Texas | 76104 | — |
| Neurocrine Clinical Site | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05206513, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 29, 2026 · Synced Nov 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05206513 live on ClinicalTrials.gov.